{
 "as_of": "2026-11-08",
 "cmr": "us-cm-kg/NASDAQ/HURA",
 "fence": "The page is the record's research on the issuer — no analyst, no rating, no view.",
 "markdown": "The page is the record's research on the issuer — no analyst, no rating, no view.\n\n# TuHURA Biosciences, Inc./NV (NASDAQ: HURA) — research page\n\nAs of 2026-11-08 · us-cm-kg · record version 1\n\n## Identity and listing\n\nThe issuer is TuHURA Biosciences, Inc./NV, listed on NASDAQ under ticker HURA, with ISIN US8989201038 and LEI 549300N7OBMRNSOQC133. Its security type is Corporate, its sector is 2834 Pharmaceutical Preparations, and its jurisdiction is United States — Nevada. Its segment is not on the record. Its listing status is listed, not halted.\n\n## The disclosure read\n\nThe record holds 51 filings in the twelve months to 2026-11-08, across 33 filing days. The median gap between filing days is 8.5 days, against a NASDAQ median of 6.0 days and a 2834 Pharmaceutical Preparations median of 6.0 days. The latest filing is dated 2026-11-06, an ad hoc filing, 2 days before the record date. The NASDAQ median latency is 5.0 days and the sector median latency is 4.0 days. The NASDAQ median filings in the window is 52, and the sector median is 63.0.\n\n## Auditor\n\nThe auditor is not on the record; the latest annual report cover carries no dei:AuditorName tag. The auditor's location is not on the record. The record holds no auditor changes.\n\n## Events and halts\n\nThe record holds no listing, delisting or name change events. The domicile change is not on the record, because EDGAR states no dated change of state of incorporation on a filing line. The segment move is not on the record, because the exchanges' tier transfers are not EDGAR filings. The halt flag is listed, not halted.\n\n## Orderability\n\nThe outcome is not determinable, because the chapter's orderability section carries no client categories and so the outcome cannot name its client category. The rule version is acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, and the chapter is as of 2026-11-04.\n\n## Coverage\n\nThe issuer's investor-relations page names 6 research houses: Brookline Capital Markets, Citizens, H.C. Wainwright & Co., Maxim Group, Rodman & Renshaw, and Zacks SCR.\n\n## Open research\n\nThe state is none found. No openly published research notes are on the record.\n\n## Licensed\n\nLicensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.\n\n## As-of depth\n\nThe record holds the issuer's sealed years 2021, 2022, 2023, 2024, 2025 and 2026. The market's vintage is sealed, with the earliest sealed date at 2021-01-04. The live record began on 2026-09-12.\n\n## Sources\n\n9 source pages are named on this page; every value above carries its own source page and read date in the numbers.\n\n- https://www.sec.gov/files/company_tickers_exchange.json (identity.exchange)\n- https://www.sec.gov/data-research/sec-markets-data/fails-deliver-data (identity.isin)\n- https://data.sec.gov/submissions/CIK0001498382.json (identity.jurisdiction)\n- https://api.gleif.org/api/v1/lei-records/549300N7OBMRNSOQC133 (identity.lei)\n- https://mcp.us-cm-kg.ai/events/NASDAQ/HURA (the disclosure lines)\n- https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts (the halt flag)\n- https://mcp.us-cm-kg.ai/book/aio.json (the orderability chapter)\n- https://ir.tuhurabio.com/stock-data/analyst-coverage (coverage)\n- https://mcp.us-cm-kg.ai/record/NASDAQ/HURA (the record)\n",
 "market": "US",
 "node": "us-cm-kg",
 "numbers": {
  "as_of_depth": {
   "issuer_years_sealed": [
    "2021",
    "2022",
    "2023",
    "2024",
    "2025",
    "2026"
   ],
   "live_record_began": "2026-09-12",
   "node_history_from": "2021-01-04",
   "node_years_sealed": [
    "2021",
    "2022",
    "2023",
    "2024",
    "2025",
    "2026"
   ],
   "record_version": 1,
   "sealed": true
  },
  "auditor": {
   "auditor": {
    "market": "US",
    "reason": "no dei:AuditorName tag on the latest annual report cover (foreign private issuers and older filings carry none)",
    "state": "not_on_record"
   },
   "auditor_firm_id": {
    "market": "US",
    "state": "not_on_record"
   },
   "auditor_location": {
    "market": "US",
    "state": "not_on_record"
   },
   "changes": []
  },
  "cmr": "us-cm-kg/NASDAQ/HURA",
  "coverage": {
   "count": 6,
   "houses": [
    {
     "analyst": "Kumaraguru Raja, PhD",
     "house": "Brookline Capital Markets",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-11",
     "source": "https://ir.tuhurabio.com/stock-data/analyst-coverage",
     "state": "sourced"
    },
    {
     "analyst": "Silvan Turkcan, PhD",
     "house": "Citizens",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-11",
     "source": "https://ir.tuhurabio.com/stock-data/analyst-coverage",
     "state": "sourced"
    },
    {
     "analyst": "Robert Burns",
     "house": "H.C. Wainwright & Co.",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-11",
     "source": "https://ir.tuhurabio.com/stock-data/analyst-coverage",
     "state": "sourced"
    },
    {
     "analyst": "Jason McCarthy, PhD",
     "house": "Maxim Group",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-11",
     "source": "https://ir.tuhurabio.com/stock-data/analyst-coverage",
     "state": "sourced"
    },
    {
     "analyst": "Michael King",
     "house": "Rodman & Renshaw",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-11",
     "source": "https://ir.tuhurabio.com/stock-data/analyst-coverage",
     "state": "sourced"
    },
    {
     "analyst": "John D. Vandermosten, CFA",
     "house": "Zacks SCR",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-11",
     "source": "https://ir.tuhurabio.com/stock-data/analyst-coverage",
     "state": "sourced"
    }
   ],
   "pages_checked": [
    {
     "page": "https://ir.tuhurabio.com/stock-data/analyst-coverage",
     "result": "read: 6 of 12 named houses found on the page"
    }
   ],
   "read_by": "Perplexity sonar (search) · page read by this rail",
   "read_date": "2026-11-11",
   "since": "not stated on the page read",
   "state": "found"
  },
  "disclosure": {
   "against": {
    "exchange": {
     "issuers": 4359,
     "median_cadence_gap_days": 6,
     "median_filings": 52,
     "median_latency_days": 5,
     "name": "NASDAQ"
    },
    "sector": {
     "issuers": 526,
     "median_cadence_gap_days": 6,
     "median_filings": 63,
     "median_latency_days": 4,
     "name": "2834 Pharmaceutical Preparations"
    }
   },
   "by_type": {
    "ad_hoc": 11,
    "agm_egm": 4,
    "corporate_news": 6,
    "director_change": 3,
    "directors_dealings": 10,
    "halt_suspension": 1,
    "prospectus": 3,
    "regulatory_filing": 4,
    "results": 9
   },
   "cadence_median_gap_days": 8.5,
   "filing_days": 33,
   "filings": 51,
   "latency_days": 2,
   "latest": [
    {
     "category": "8-K",
     "date": "2026-11-06",
     "source": "https://www.sec.gov/Archives/edgar/data/1498382/000119312526452007/hura-20261102.htm",
     "title": "8-K — 8-K (items 2.03,9.01)",
     "type": "ad_hoc"
    },
    {
     "category": "8-K",
     "date": "2026-10-16",
     "source": "https://www.sec.gov/Archives/edgar/data/1498382/000119312526424228/hura-20261009.htm",
     "title": "8-K — 8-K (items 2.03,9.01)",
     "type": "ad_hoc"
    },
    {
     "category": "8-K",
     "date": "2026-09-24",
     "source": "https://www.sec.gov/Archives/edgar/data/1498382/000119312526401140/hura-20260921.htm",
     "title": "8-K — 8-K (items 2.03,9.01)",
     "type": "ad_hoc"
    },
    {
     "category": "8-K",
     "date": "2026-09-17",
     "source": "https://www.sec.gov/Archives/edgar/data/1498382/000119312526394473/hura-20260914.htm",
     "title": "8-K — 8-K (items 2.03,9.01)",
     "type": "ad_hoc"
    },
    {
     "category": "8-K/A",
     "date": "2026-09-17",
     "source": "https://www.sec.gov/Archives/edgar/data/1498382/000119312526393847/hura-20260910.htm",
     "title": "8-K/A — 8-K/A (items 5.02,9.01)",
     "type": "director_change"
    }
   ],
   "latest_filing_date": "2026-11-06",
   "read": "the node's event lines (list_events_since), as get_filings serves them",
   "source": "https://mcp.us-cm-kg.ai/events/NASDAQ/HURA",
   "window": {
    "from": "2025-11-08",
    "to": "2026-11-08"
   }
  },
  "identity": {
   "exchange": {
    "read_by": "EDGAR company_tickers_exchange.json (SEC list of exchange-listed filers)",
    "read_date": "2026-11-08",
    "read_date_basis": "the record version as_of",
    "source": "https://www.sec.gov/files/company_tickers_exchange.json",
    "state": "sourced",
    "value": "NASDAQ"
   },
   "isin": {
    "read_by": "SEC Fails-to-Deliver data (CUSIP for the symbol) · ISIN = US + CUSIP + ISO 6166 check digit",
    "read_date": "2026-10-14",
    "read_date_basis": "last_seen",
    "source": "https://www.sec.gov/data-research/sec-markets-data/fails-deliver-data",
    "state": "sourced",
    "value": "US8989201038"
   },
   "jurisdiction": {
    "read_by": "EDGAR submissions API (issuer header as filed) (stateOfIncorporation)",
    "read_date": "2026-11-08",
    "read_date_basis": "the record version as_of",
    "source": "https://data.sec.gov/submissions/CIK0001498382.json",
    "state": "sourced",
    "value": "United States — Nevada"
   },
   "lei": {
    "read_by": "GLEIF name-exact (suffix-insensitive) (jurisdiction US-NV; GLEIF golden copy 2026-09-12)",
    "read_date": "2026-11-08",
    "read_date_basis": "the record version as_of",
    "source": "https://api.gleif.org/api/v1/lei-records/549300N7OBMRNSOQC133",
    "state": "filled",
    "value": "549300N7OBMRNSOQC133"
   },
   "name": {
    "read_by": "EDGAR submissions API (issuer header as filed)",
    "read_date": "2026-11-08",
    "read_date_basis": "the record version as_of",
    "source": "https://data.sec.gov/submissions/CIK0001498382.json",
    "state": "sourced",
    "value": "TuHURA Biosciences, Inc./NV"
   },
   "sector": {
    "read_by": "EDGAR submissions API (issuer header as filed) (SIC code as assigned by the SEC)",
    "read_date": "2026-11-08",
    "read_date_basis": "the record version as_of",
    "source": "https://data.sec.gov/submissions/CIK0001498382.json",
    "state": "sourced",
    "value": "2834 Pharmaceutical Preparations"
   },
   "security_type": {
    "read_by": "EDGAR submissions API (issuer header as filed)",
    "read_date": "2026-11-08",
    "read_date_basis": "the record version as_of",
    "source": "https://data.sec.gov/submissions/CIK0001498382.json",
    "state": "sourced",
    "value": "Corporate"
   },
   "segment": {
    "market": "US",
    "state": "not_on_record"
   },
   "ticker": {
    "read_by": "EDGAR company_tickers_exchange.json (SEC list of exchange-listed filers)",
    "read_date": "2026-11-08",
    "read_date_basis": "the record version as_of",
    "source": "https://www.sec.gov/files/company_tickers_exchange.json",
    "state": "sourced",
    "value": "HURA"
   },
   "website": {
    "market": "US",
    "state": "not_on_record"
   }
  },
  "licensed": {
   "columns": [
    "licensor",
    "entitlement",
    "title",
    "date",
    "source"
   ],
   "rows": [],
   "rule": "A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded."
  },
  "lifecycle": {
   "delisting": [],
   "domicile_change": {
    "market": "US",
    "reason": "EDGAR states no dated change of state of incorporation on a filing line",
    "state": "not_on_record"
   },
   "listing": [],
   "name_change": [],
   "segment_move": {
    "market": "US",
    "reason": "the exchanges' tier transfers are not EDGAR filings",
    "state": "not_on_record"
   }
  },
  "market": "US",
  "node": "us-cm-kg",
  "numbers_hash": "sha256:6b160e4fcd4998410acff748f604f75ddc36940ea55faeb4dfd7238d61dda230",
  "open_research": {
   "read_date": "2026-11-11",
   "rows": [],
   "state": "none_found"
  },
  "orderability": {
   "chapter_as_of": "2026-11-04",
   "client_categories": [],
   "determinable": false,
   "read": {
    "chapter": "https://mcp.us-cm-kg.ai/book/aio.json",
    "door": "https://mcp.us-cm-kg.ai/mcp",
    "tool": "get_orderability"
   },
   "reason": "the chapter's orderability section carries no client_categories: the outcome cannot name its client category",
   "rule_version": "acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1",
   "section": "us.aio.v8"
  },
  "record": {
   "as_of": "2026-11-08",
   "url": "https://mcp.us-cm-kg.ai/record/NASDAQ/HURA",
   "version": 1
  },
  "schema": "research-numbers v0.1 (USR-01, 2026-11-11)",
  "status": {
   "read_date": "2026-11-08",
   "source": "https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts",
   "value": "listed, not halted"
  }
 },
 "numbers_hash": "sha256:6b160e4fcd4998410acff748f604f75ddc36940ea55faeb4dfd7238d61dda230",
 "path": "/us/NASDAQ/HURA",
 "schema": "research-page v0.1 (USR-02, 2026-11-11)",
 "sections": [
  {
   "id": "identity",
   "text": "The issuer is TuHURA Biosciences, Inc./NV, listed on NASDAQ under ticker HURA, with ISIN US8989201038 and LEI 549300N7OBMRNSOQC133. Its security type is Corporate, its sector is 2834 Pharmaceutical Preparations, and its jurisdiction is United States — Nevada. Its segment is not on the record. Its listing status is listed, not halted.",
   "title": "Identity and listing"
  },
  {
   "id": "disclosure",
   "text": "The record holds 51 filings in the twelve months to 2026-11-08, across 33 filing days. The median gap between filing days is 8.5 days, against a NASDAQ median of 6.0 days and a 2834 Pharmaceutical Preparations median of 6.0 days. The latest filing is dated 2026-11-06, an ad hoc filing, 2 days before the record date. The NASDAQ median latency is 5.0 days and the sector median latency is 4.0 days. The NASDAQ median filings in the window is 52, and the sector median is 63.0.",
   "title": "The disclosure read"
  },
  {
   "id": "auditor",
   "text": "The auditor is not on the record; the latest annual report cover carries no dei:AuditorName tag. The auditor's location is not on the record. The record holds no auditor changes.",
   "title": "Auditor"
  },
  {
   "id": "events",
   "text": "The record holds no listing, delisting or name change events. The domicile change is not on the record, because EDGAR states no dated change of state of incorporation on a filing line. The segment move is not on the record, because the exchanges' tier transfers are not EDGAR filings. The halt flag is listed, not halted.",
   "title": "Events and halts"
  },
  {
   "id": "orderability",
   "text": "The outcome is not determinable, because the chapter's orderability section carries no client categories and so the outcome cannot name its client category. The rule version is acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, and the chapter is as of 2026-11-04.",
   "title": "Orderability"
  },
  {
   "id": "coverage",
   "text": "The issuer's investor-relations page names 6 research houses: Brookline Capital Markets, Citizens, H.C. Wainwright & Co., Maxim Group, Rodman & Renshaw, and Zacks SCR.",
   "title": "Coverage"
  },
  {
   "id": "open_research",
   "text": "The state is none found. No openly published research notes are on the record.",
   "title": "Open research"
  },
  {
   "id": "licensed",
   "text": "Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.",
   "title": "Licensed"
  },
  {
   "id": "depth",
   "text": "The record holds the issuer's sealed years 2021, 2022, 2023, 2024, 2025 and 2026. The market's vintage is sealed, with the earliest sealed date at 2021-01-04. The live record began on 2026-09-12.",
   "title": "As-of depth"
  },
  {
   "id": "sources",
   "text": "9 source pages are named on this page; every value above carries its own source page and read date in the numbers.",
   "title": "Sources"
  }
 ],
 "sources": [
  {
   "for": "identity.exchange",
   "source": "https://www.sec.gov/files/company_tickers_exchange.json"
  },
  {
   "for": "identity.isin",
   "source": "https://www.sec.gov/data-research/sec-markets-data/fails-deliver-data"
  },
  {
   "for": "identity.jurisdiction",
   "source": "https://data.sec.gov/submissions/CIK0001498382.json"
  },
  {
   "for": "identity.lei",
   "source": "https://api.gleif.org/api/v1/lei-records/549300N7OBMRNSOQC133"
  },
  {
   "for": "the disclosure lines",
   "source": "https://mcp.us-cm-kg.ai/events/NASDAQ/HURA"
  },
  {
   "for": "the halt flag",
   "source": "https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts"
  },
  {
   "for": "the orderability chapter",
   "source": "https://mcp.us-cm-kg.ai/book/aio.json"
  },
  {
   "for": "coverage",
   "source": "https://ir.tuhurabio.com/stock-data/analyst-coverage"
  },
  {
   "for": "the record",
   "source": "https://mcp.us-cm-kg.ai/record/NASDAQ/HURA"
  }
 ],
 "title": "TuHURA Biosciences, Inc./NV (HURA) — research page",
 "writer": {
  "by": "Claude through the platform account, Haiku class; one pass; checked against the numbers",
  "engine": "claude-haiku-5-5"
 }
}